ReviewMolecules (Basel, Switzerland)2018
Chemical Components and Biological Activities of the Genus
Review in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 114 citations in OpenAlex.
- The Role of Ethyl Acetate Fraction fromMolecules (Basel, Switzerland) · 2026Article
- Therapeutic potential ofRSC advances · 2025Review
- Enhancing the bioavailability ofAnnals of medicine and surgery (2012) · 2025Review
- Medicinal plants traditionally used for management of malaria in rural communities of Uganda.BMC complementary medicine and therapies · 2025Article
- Polyherbal Formulation as a Therapeutic Strategy for Lung Cancer: Phytochemical Profiling, Molecular Docking, and Pharmacological Evaluation.Asian Pacific journal of cancer prevention : APJCP · 2025Article
- New Terpenoids and Lignans fromFoods (Basel, Switzerland) · 2025Article
- Molecular Mechanisms Underlying the Therapeutic Potential of Plant-Based α-Amylase Inhibitors for Hyperglycemic Control in Diabetes.Current diabetes reviews · 2025Review
- Impacts ofNarra J · 2024Article
- Chemical Composition and Bioactivity Dataset Integration to Identify Antiproliferative Compounds inPharmaceutics · 2024Article
- Flavonoids: Antioxidant Powerhouses and Their Role in Nanomedicine.Antioxidants (Basel, Switzerland) · 2024Review
- The effect ofFrontiers in microbiology · 2024Article
- Evaluation of Salicylic Acid and Methyl Jasmonate as Elicitors inMolecules (Basel, Switzerland) · 2023Article
- Assessment of in vitro anti-skin aging activities of Phyllanthus indofischeri Bennet extracts for dermatological and aesthetic applications.Scientific reports · 2023Article
- Advances in Phytonanotechnology: A Plant-Mediated Green Synthesis of Metal Nanoparticles UsingNanomaterials (Basel, Switzerland) · 2023Review
- Hypophyllanthin and Phyllanthin fromACS omega · 2023Article
- A new class of potent liver injury protective compounds: Structural elucidation, total synthesis and bioactivity study.Acta pharmaceutica Sinica. B · 2023Article
- Cytotoxic and chemomodulatory effects of Phyllanthus niruri in MCF-7 and MCF-7Scientific reports · 2023Article
- Attenuation of Hyperlipidemia by Medicinal Formulations ofBioengineering (Basel, Switzerland) · 2023Review
- Article
- Phyllanthus amarus shoot cultures as a source of biologically active lignans: the influence of selected plant growth regulators.Scientific reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
Abstract
Medicinal plants have served humans since prehistoric times to treat various ailments. Both developed and underdeveloped countries rely on traditional systems of medication using natural sources from plants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.